Introduction
Idiopathic pulmonary arterial hypertension is characterized by pathological neointima formation within small pulmonary arteries, leading to increased pulmonary vascular resistance and arterial pressure, which in turn causes right ventricle congestive failure and eventual death 1 . In susceptible individuals, diverse endothelial injuries trigger vascular dysfunction, including insufficient vasodilation, excessive vasoconstriction, enhanced growth of smooth muscles and prominent perivascular inflammation 2 .
The pathologic lesions of pulmonary hypertension demonstrate features of intimal proliferation, medial hypertrophy and adventitial fibrosis 3, 4 . Small pulmonary arteries exhibit greater luminal narrowing associated with neointima formation than muscularization of the medial wall. Chronic severe pulmonary vascular disease is associated with plexiform lesions that demonstrate "a central zone of proliferative endothelial tissue," often associated with a thrombus and eventual replacement by fibrous tissue 5 .
The expression of smooth muscle alpha-actin (SMA) within neointimal cells has long raised questions for pathologists about what cell lineage(s) contribute to the neointima. The most likely cell lineages that may contribute to the pathologic neointima include, vascular smooth muscle cells undergoing dedifferentiation, myofibroblasts derived from migrating adventitial fibroblasts, and endothelial cells transitioning into mesenchymal cells (EnMT) 6, 7 .
Expression of the endothelial von Willebrand antigen in plexiform lesions and microsatellite analyses were used to infer that individual plexiform lesions represent monoclonal expansions of endothelial cells 8 .
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Whereas models based on hypoxia demonstrate predominantly hypertrophy of medial smooth muscles, models based on endothelial injury following exposure to SU5416 or monocrotaline, trigger more local inflammation and proliferative neointimal lesions that exhibit pathologies similar to human idiopathic pulmonary arterial hypertension. Endothelial injury models of experimental pulmonary hypertension are augmented by combination with a second stimulus such as hypoxia exposure following SU5416, and pneumonectomy prior to monocrotaline.
The Crotalaria plant alkaloid, monocrotaline, undergoes hepatic metabolism in many species (except mice) into monocrotaline pyrrole (MCTP), which reacts covalently with pulmonary endothelial cells triggering megalocytosis, microvascular leak, mononuclear cell infiltration and alterations in muscular walls that lead to pulmonary hypertension [10] [11] [12] [13] [14] . The addition of surgical pneumonectomy to monocrotaline injection (60 mg/kg, single injection subcutaneously) produced greater experimental pulmonary hypertension with severe neointimal formation in rats compared to monocrotaline alone 15, 16 . Surgical pneumonectomy increases blood flow and also triggers compensatory lung growth in the remaining lung. We tested the hypothesis that increased blood flow contributes to the pathogenesis of experimental pulmonary hypertension by surgical creation of an aorto-caval fistula to further increase pulmonary blood flow in pneumonectomized rats injected with monocrotaline 16 . Unexpectedly, we discovered that increased pulmonary blood flow in rats with an aorto-caval fistula reduced the severity of pulmonary hypertension. We proposed that increased oxygen concentration in the mixed venous blood of animals with an aorto-caval fistula conferred protection against neointima formation and pulmonary hypertension. In this rat model of experimental pulmonary hypertension we concluded that pneumonectomy amplifies the pathophysiology of disease through induction of pulmonary endothelial cells triggering megalocytosis, microvascular leak, mono on n nucl cl c e ea ar r ce ce cell ll ll nfiltration and alterations in muscular walls that lead to pulmonary hypertension [10] [11] [12] [13] [14] . The ad ddi di diti ti tion on on o o of f f su su surgic ic ca al al pneumonectomy to monocro o ota ta t l li ine injection ( (60 6 6 m mg/ g/ g/k k kg, single injection u ubc bc cut u aneously ly) ) ) pr r rod od du u uced ed ed g g gre re rea at ater er r e ex xp xper eri imen n nt ta al pu ul lm mo on ona ar ary y y h hy ype pe ert rten ensi si io on on w wit it ith h h se seve ve vere re e n neo o oin in inti ti tim m mal fo orm rm rmat at atio ion n in in in r rat ats s c co omp mp mpar ar red ed t to o o mo mo mono no nocr cro ot otal al alin in ine e al al alon on ne 15, 1 16 16 . Su Su Surg g gic ic i a a al p p pne ne n um um umon one ec ecto to tomy my my i i inc cr re reas ases es s blood flow a and nd nd a als ls so o o tr tr rig ig igge gers rs rs c c com m mpe pe p ns ns n at at ator or ory y y lu lu lung ng ng gr gr grow ow owth h h i i in n n th th the e re re rema ma main in inin in ing g g lu lu lung ng n . . We We We t t tes es e ted the compensatory lung growth. We and others, employed rat models of experimental pulmonary hypertension triggered by endothelial injury to characterize novel antiproliferative strategies to reverse established pulmonary vascular disease, such as simvastatin [17] [18] [19] [20] .
In contrast to rats, mice are relatively resistant to induction of pulmonary hypertension by monocrotaline 21 . Mice administered monocrotaline at 24 mg/kg/day in the drinking water for 6 weeks (ten times higher dose than required in rats to produce equivalent degree of pulmonary endothelial dysfunction) demonstrated lung edema and inflammation but did not develop significant occlusive wall thickening of pulmonary arteries. Recently, several groups reported that injection of 300 or 600 mg/kg monocrotaline (ten times higher dose than used in rats)
subcutaneously once per week for 4 to 10 weeks, produced mild increases in right ventricular systolic pressures, right ventricular hypertrophy and vascular narrowing [22] [23] [24] [25] . As in rats, monocrotaline induction of pulmonary hypertension in mice is characterized by perivascular accumulation of inflammatory cells.
Monocrotaline pyrrole is the active metabolite of monocrotaline and is 200-400 times more potent in producing cell injury and triggering the development of pulmonary hypertension 26, 27 . We synthesized monocrotaline pyrrole by chemical dehydration as described by Mattocks 28 , for direct injection through the jugular vein into the pulmonary circulation to trigger endothelial injury and pulmonary hypertension. Based on our experience in rats 16 , we elected to combine pneumonectomy with injection of monocrotaline pyrrole into the pulmonary circulation with the intention of producing a two-hit mouse model that demonstrated substantial pulmonary hypertension with neointima formation.
Genetic lineage marking achieved through Cre-directed recombination at loxP sites permanently alters the genome such that a given cell and all its progeny are indelibly labeled 29 .
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Methods

Monocrotaline pyrrole (MCTP) synthesis
Dehydromonocrotaline, which is monocrotaline pyrrole (MCTP), was synthesized from monocrotaline (MCT, Sigma) by the method of A.R. Mattocks et al. 28 . Using mass spectrometry and nuclear magnetic resonance spectroscopy the conversion of MCT to MCTP was found to be complete. For the starting product the parent peak is at m/e 326, and the desired peak for MCTP is at m/e 324. The mass spectra of the product contained daughter ions characteristic of MCTP.
The MCTP was dissolved in anhydrous acetonitrile to a final concentration of 20μg/μL, the product was aliquoted into vials (500μl), the solvent was evaporated, and the lyophilized MCTP was stored at -80°C, shielded from light, until just prior to use. Five minutes before injection into mice, MCTP was dissolved into dimethyl formamide (DMF).
The study was approved by the Stanford Administrative Panel on Laboratory Animal
Care and all animals received humane care.
Left Pneumonectomy
Mice were anesthesized in a plastic box by exposure to 2.5% isoflurane for five minutes.
Endotracheal intubation was performed using a 20g teflon catheter over a fiberoptic light and stylus (Kent Scientific Corporation, Torrington, CT). After intubation, mice were mechanically monocrotaline (MCT, Sigma) by the method of A.R. Mattocks et al. 28 . Using ma ma ass s spe pe pect ct ctro ro rome me m try y and nuclear magnetic resonance spectroscopy the conversion of MCT to MCTP was found to be co omp mp mple le let te te. Fo Fo For r r th he e e s st starting product the parent peak ak ak i is s at m/e 326, an an and th th he e e d desired peak for MCTP k s s a at t t m/e 324. T T Th he h m mas ass sp sp spec ec ectr tr tra a of of f t the he h p pr r rodu u uct t t con n nt ta aine e ed d d da da aug g ght hte er er i ion ons s c ch har ar rac ac acte teri ri ist st s ic ic ic o of f MC MC MCTP TP TP.
Th Th he e e M MC MCTP TP P w w was as d di is sso sol lve ed ed in n an anhy hy hydr dr drou ou us s ac ac acet et eton n nit it i ri ri ile e to to o a a f f fin in inal al c c con on nce ce ent nt n r ra a ati io ion n of of of 2 20μ 0μ 0μg g/ g/μL μL L, th the e isoflurane. Mice were positioned supine, the forelimbs were gently retracted with tape, and the sternum and left chest were cleaned by aseptic technique. Left thoracotomy was performed in the fourth intercostal space using atraumatic technique and the ribs were retracted using two hooks fashioned from large-size paper clips. The left lung was gently lifted out of the chest, the hilum was clamped with an atraumatic mosquito clamp and ligated using 4-0 silk suture and the left pneumonectomy was completed using aseptic technique. Isoflurane was turned to 0% while the ribs were closed with a single 4-0 suture and the skin was closed with two 4-0 sutures. When mice were confirmed awake by spontaneous ventilation and appropriate movement in response to stimulation, the mice were extubated and transferred into a warm recovery cage (30-35 F, 2 l/m oxygen) for 2 h. Survival one day after pneumonectomy was 90-100%.
Monocrotaline pyrrole (MCTP) administration
One week after left pneumonectomy, mice were anesthetized in a plastic box using 2.0%
isoflurane, then positioned supine and anesthesia was maintained by hood ventilation using 1%
isoflurane. The right internal jugular vein was exposed using aseptic technique. Monocrotaline pyrrole was freshly resuspended in DMF (20μg/μl). A Hamilton syringe attached to PE-tubing with a 30g needle was backfilled with 100μl of DMF, then MCTP in DMF (~30 μl) was aspirated into the tubing for injection at a concentration of 20μg/g mouse weight (1 μl/g). A dissecting microscope was used to guide the needle into the right internal jugular vein and the MCTP was injected slowly over approximately one minute. After removing the needle, pressure was applied to the injection site indirectly though a layer of fatty tissue until hemostasis was complete, then the skin was closed using two 4-0 sutures. Survival at 3 days after MCTP mice were confirmed awake by spontaneous ventilation and appropriate moveme me ent nt i in re r resp sp spon on onse se o stimulation, the mice were extubated and transferred into a warm recovery cage (30-35 F, 2 /m m ox ox oxyg yg ygen en en) ) ) f f for 2 2 2 h h. h. Survival one day after pneu u umo mo monectomy was 90 9 9 -1 100 00 00% %.
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injection was approximately 75%.
Hemodynamic studies
For hemodynamic measurements, mice were anesthetized in a plastic box using 2% isoflurane, then placed in a supine position and anesthesia was maintained using 1% isoflurane delivered by hood. Right ventricular systolic pressure (RVSP) measurements were obtained by percutaneous needle (30 gauge) puncture of the right ventricle or through use of a Millar catheter (SPR-1000)
inserted through the right internal jugular vein and a PowerLab data acquisition system (AD Instruments, Colorado Springs, CO).
Tissue preparation and histology
Anesthetized mice were euthanized by exsanguination. The heart and lungs were perfused with phosphate buffered saline (PBS) followed by 10% neutral buffered formalin. The heart was weighed and right ventricular hypertrophy was determined by Fulton's Index: (right ventricle / (left ventricle and septum)). The formalin-fixed lungs were embedded in paraffin and fivemicron sections were stained with hematoxylin and eosin (H&E) and with elastin-van Gieson (EVG) to mark internal elastic lamina. Vascular narrowing associated with neointima formation was evaluated as described previously 18, 30, 31 : absence of neointima formation was scored 0, neointima formation causing less than 50% luminal narrowing was scored 1, and luminal narrowing greater than 50% was scored 2. The scores of 15 consecutive inter-acinar pulmonary arteries were assessed to determine the relative vascular occlusion score (VOS).
Immunohistochemistry was performed on formalin-fixed lung sections stained with a biotinylated monoclonal antibody against -smooth muscle actin (Clone 1A4, Dako), and detection was performed using streptavidin-peroxidase and diaminobenzidine substrate.
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In the pilot study, four male C57Bl/6 mice (body weight 24-28g) underwent left pneumonectomy In the main physiology study, 42 pathogen-free, twelve-week old, male C57Bl/6 mice (body weight 24-28g) were studied in five groups: Group C (n = 6) served as a reference control, 
Statistical analysis
Data are presented as means standard deviations. The pilot study of RVSP was analyzed using a repeated measures analysis of variance (ANOVA) followed by Newman-Keuls tests. The vascular occlusion scores (VOS) of control and P/MCTP mice were compared by t-test. In the main study, Groups V, P, MCTP, and P/MCTP were analyzed by ANOVA and Newman-Keuls tests and also using nonparametric Kruskal-Wallis ANOVA (StatPlus software). Statistical significance was indicated by p < 0.05.
Genetic Lineage Marking
Double transgenic mice with endothelial genetic lineage marking were generated by intercrossing VE-Cadherin Cre 29 or Tie-2 Cre 32 recombinase driver mice with mTomato/mGFP floxed dual fluorescent Cre reporter mice 33 . Cre-mediated excision of the membrane-targeted dTomato gene is accompanied by expression of membrane-targeted eGFP in endothelial cells. 
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Immunofluorescence
After sacrifice by exsanguination, the right lung was perfused with PBS followed by 2%
paraformaldehyde. Lung lobes were immersed in 2% paraformaldehyde for 2h, followed by dehydration in 30% sucrose overnight and embedding in optimal cutting temperature compound (OCT). Cryosections were cut at 40μM thickness. Experiments conducted using isotype control antibodies, mouse IgG1 and IgG2a (Abcam), in primary incubations followed by secondary detection using Alexa Fluor 647 goat anti-mouse IgG1 or IgG2a, demonstrated no specific labeling on the lung sections (data not shown).
Confocal microscopy was performed using a Leica DMI 6000 equipped with BD Carv II confocal imager, Chroma Photofluor metal halide illumination and Leica Imaging Software.
Sequential 1μM optical sections were acquired at 350 (DAPI), 488 (GFP), 568 (dTomato) and 647 nm (immunostaining) wavelengths, and contrast was enhanced using deconvolution software 
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Genetic lineage marking and confocal microscopy
Dual fluorescent Cre recombinase reporter mice, mT/mG, were intercrossed with transgenic endothelial Cre driver mice, VE-Cad Cre 29 or Tie-2 Cre 32 , and progeny were genotyped to identify the mice that carried both Cre and GFP. These mice demonstrated strong red fluorescence in un-recombined cells, and strong green fluorescence in vascular structures (Figures 3-7) . The fidelity of VE Cad Cre-directed endothelial genetic lineage marking in Control mice (indicated by GFP labeling in green, Figure 3A ,C,D,F) was assessed by immunostaining of endothelial antigens, VE-Cadherin ( Figure 3B ,C, cyan) and CD31 ( Figure   3E ,F, cyan). Endothelial immunostaining co-localized over green endothelial genetic-lineage marked cells, and did not co-localize over red cells (Figure 3C,F) . The strong expression of membrane-targeted GFP that outlined the recombined cells provided greater clarity than antigen staining for identifying cells that expressed an endothelial phenotype.
Induction of experimental pulmonary hypertension with neointima reveals contribution by
GFP-marked cells of endothelial genetic lineage
VE-Cad Cre x mT/mG mice were analyzed as Controls or were subjected to the model of experimental pulmonary hypertension that induces neointima formation (P/MCTP). The MCTP used in the study of fluorescently labeled mice had been stored at -80 C for 7 years, and we found it to be less potent than previously observed in our main physiology study (Figure 1,2) .
The fluorescently-labeled pneumonectomized mice injected with MCTP (20μg/g) developed moderate pulmonary hypertension (RVSP ~40 mmHg) over a period of 7-10 weeks. The confocal images (Figure 3-7) are obtained from representative pulmonary hypertensive mice with endothelial genetic lineage marking.
A representative small pulmonary artery of a Control mouse viewed in cross-section marked cells, and did not co-localize over red cells (Figure 3C,F) . The strong e ex x xpre r r s ss sio io ion n n of of of membrane-targeted GFP that outlined the recombined cells provided greater clarity than antigen t tai ai ini ni ning ng ng f f for or or i i id d dent nt tif if ify ying cells that expressed an e en nd ndo o othelial phenoty ty type. . 
4F; Supplemental Movie 2).
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Discussion
We tested the hypothesis that neointima formation in experimental pulmonary hypertension originates from the endothelial genetic lineage. We developed a mouse model of pulmonary hypertension that involves surgical left pneumonectomy followed one week later by jugular vein 
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We tested th he e hy hy hypo po poth th thes es e is i i t tha ha hat t t ne ne eoi oi o nt nt ntim im ma a a fo fo form rm rmat at atio io ion n n in in n exp xp xper er eri ime me ment nt ntal al p p pul ul ulmo mo mona na nary ry y h h hyp yp yper er erte te t nsion experimental pulmonary hypertension that was principally related to respiratory distress that developed in the first two days after injection of MCTP. The quality of synthetic MCTP is important for the success of this mouse model. In spite of these technical challenges, this model enables characterization of cellular and molecular pathogenesis of pulmonary hypertension and neointima formation in genetically modified mice.
During endothelial differentiation the expression of Tie-2 precedes the expression of VE- Karasak and colleagues to conclude that the myofibroblasts were derived from dermal microvascular endothelial cells [41] [42] [43] . In this mouse model of experimental pulmonary hypertension, injury to pulmonary endothelial cells by MCTP eventually leads to activation of a program of smooth muscle gene expression. Our studies involved confocal microscopy using four distinct color channels, one of which was available for immunostaining. We therefore were Karasak and colleagues to conclude that the myofibroblasts were derived from dermal mi micr cr crov ov ovas ascu cu cul la lar r en en nd do doth t elial cells [41] [42] [43] . In this mous us use e m model of exper er rim i en en nta ta tal l pulmonary h hy hyp pe pertension, in inj ju j r ry ry t to o o p pu pulm lm lmon on onar ary y y e en end d dot t theli i ial l l cel ll ls s by y M MC MCTP TP TP e ev ve vent ntua uall l l y y y le lead ad ads s to to act ct c iv iv ivat tio io ion n of f f a pr prog og ogra ra ram m m of of f s s smo moo o oth h h mu mus sc cle le g gen en e e e e ex ex exp pr pre es ssi si ion on on. . Ou Ou Our r st stu u udi ie ies s s in in invo vo olv lv lve ed ed c c con on o f f foc c cal al m m mic ic icro ro osc sc scop opy y y u us usin in ng g f f four distinct co co colo lo l r r r ch ch chan an anne n n ls ls s, , , on o o e e e of of o w w whi hi ich ch ch w w was as as av av avai ai ila la abl b e e e fo fo for r r im im immu mu m no no nost st stai ai aini ni ning ng ng. W W We e e th th ther er e efore were e e endothelial antigens, CD31 or VWF. Neointimal expression of VWF was more extensive than of CD31. These results in human PAH lesions support our conclusions derived from mice, that at least a fraction of the pathologic neointima originates from the endothelial genetic lineage.
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